Biora Therapeutics (BIOR) Stock Chart & Stock Price History → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free BIOR Stock Alerts $0.75 +0.03 (+4.18%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Biora Therapeutics Stock Price Performance5 Day Performance+1.92%1 Month Performance+6.43%3 Month Performance-12.87%6 Month Performance-50.00%Year-To-Date Performance-44.81%1 Year Performance-73.77% Receive BIOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. BIOR Stock Chart for Thursday, May, 9, 2024 BIOR Chart by TradingView Biora Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.74$0.72-3.28%$0.75$0.72133,141 shs$25.70 million05/07/2024$0.75$0.74-1.45%$0.76$0.73113,447 shs$26.57 million05/06/2024$0.73$0.75+2.78%$0.77$0.72268,608 shs$26.96 million05/03/2024$0.71$0.73+2.55%$0.75$0.67266,983 shs$26.23 million05/02/2024$0.64$0.71+11.03%$0.72$0.63426,062 shs$25.58 million05/01/2024$0.66$0.64-2.04%$0.65$0.62287,635 shs$23.04 million Get the Latest News and Ratings for BIOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.62$0.66+5.29%$0.66$0.62254,329 shs$23.52 million04/29/2024$0.63$0.62-0.83%$0.64$0.61123,042 shs$22.34 million04/26/2024$0.61$0.63+3.41%$0.63$0.60133,471 shs$22.52 million04/25/2024$0.62$0.61-2.08%$0.63$0.60137,156 shs$21.78 million04/24/2024$0.64$0.62-2.99%$0.65$0.60184,320 shs$22.24 million04/23/2024$0.61$0.64+5.43%$0.66$0.62382,904 shs$22.93 million04/22/2024$0.62$0.61-1.45%$0.61$0.59160,188 shs$21.75 million04/19/2024$0.60$0.62+2.59%$0.62$0.60104,506 shs$22.07 million04/18/2024$0.64$0.60-6.63%$0.68$0.59519,041 shs$23.04 million04/17/2024$0.62$0.64+3.40%$0.67$0.62278,322 shs$23.04 million04/16/2024$0.62$0.62+0.16%$0.65$0.61216,467 shs$22.28 million04/15/2024$0.67$0.62-7.60%$0.67$0.61449,559 shs$22.25 million04/12/2024$0.70$0.67-4.81%$0.70$0.66294,875 shs$24.08 million04/11/2024$0.70$0.70+0.84%$0.72$0.68162,678 shs$21.37 million04/10/2024$0.70$0.70-0.14%$0.71$0.67301,229 shs$21.19 million04/09/2024$0.73$0.70-3.54%$0.72$0.68509,538 shs$21.22 million04/08/2024$0.72$0.73+0.65%$0.74$0.70297,148 shs$22.00 million04/05/2024$0.72$0.72+0.36%$0.74$0.71326,309 shs$21.85 million04/04/2024$0.75$0.72-3.57%$0.75$0.671.14 million shs$19.55 million04/03/2024$0.74$0.75+0.65%$0.77$0.73784,310 shs$20.27 million04/02/2024$0.74$0.74+0.67%$0.75$0.71606,188 shs$20.14 million04/01/2024$1.10$0.74-33.15%$0.82$0.674.29 million shs$20.01 million03/29/2024$1.10$1.10$1.17$1.08357,256 shs$29.93 million03/28/2024$1.17$1.10-5.98%$1.17$1.08353,649 shs$29.93 million03/27/2024$1.33$1.17-12.03%$1.24$1.16701,572 shs$31.84 million03/26/2024$1.22$1.33+9.02%$1.33$1.22393,881 shs$36.19 million03/25/2024$1.20$1.22+1.67%$1.23$1.16196,685 shs$33.20 million03/22/2024$1.19$1.20+0.84%$1.23$1.16189,709 shs$32.65 million03/21/2024$1.21$1.19-1.65%$1.21$1.16158,864 shs$32.38 million03/20/2024$1.19$1.21+1.68%$1.22$1.15284,543 shs$32.92 million03/19/2024$1.15$1.19+3.48%$1.23$1.12176,743 shs$32.38 million03/18/2024$1.12$1.15+2.68%$1.18$1.09162,670 shs$31.29 million03/15/2024$1.08$1.12+3.70%$1.19$1.08342,208 shs$30.48 million03/14/2024$1.15$1.08-6.09%$1.14$1.01282,488 shs$29.39 millionThe ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.03/13/2024$1.13$1.15+1.77%$1.20$1.12243,780 shs$31.29 million03/12/2024$1.27$1.13-11.02%$1.26$1.12365,665 shs$30.75 million03/11/2024$1.19$1.27+6.72%$1.31$1.26557,014 shs$34.56 million03/08/2024$1.16$1.19+2.59%$1.20$1.14211,211 shs$32.38 million03/07/2024$1.18$1.16-1.28%$1.21$1.13361,995 shs$31.56 million03/06/2024$1.10$1.18+6.82%$1.20$1.07326,134 shs$31.97 million03/05/2024$1.24$1.10-11.29%$1.27$1.10499,235 shs$29.93 million03/04/2024$1.15$1.24+7.83%$1.31$1.15869,599 shs$33.74 million03/01/2024$1.31$1.15-12.21%$1.37$1.07604,537 shs$31.29 million02/29/2024$1.42$1.31-7.75%$1.54$1.25516,787 shs$35.65 million02/28/2024$1.54$1.42-7.79%$1.99$1.351.95 million shs$38.64 million02/27/2024$1.05$1.54+46.67%$1.54$1.092.35 million shs$41.90 million02/26/2024$0.85$1.05+23.70%$1.09$0.87657,026 shs$28.57 million02/23/2024$0.82$0.85+3.63%$0.85$0.78126,345 shs$23.10 million02/22/2024$0.84$0.82-2.49%$0.89$0.79151,511 shs$22.29 million02/21/2024$0.89$0.84-5.45%$0.90$0.81121,290 shs$22.86 million02/20/2024$0.83$0.89+7.04%$0.89$0.85223,221 shs$24.17 million02/19/2024$0.83$0.83$0.85$0.77246,100 shs$22.58 million02/16/2024$0.81$0.83+2.60%$0.85$0.77243,849 shs$22.58 million02/15/2024$0.82$0.81-1.58%$0.83$0.80200,289 shs$22.01 million02/14/2024$0.81$0.82+1.96%$0.84$0.78172,573 shs$22.37 million02/13/2024$0.84$0.81-4.14%$0.85$0.77219,774 shs$21.94 million02/12/2024$0.86$0.84-1.64%$0.88$0.84175,099 shs$22.88 million02/09/2024$0.84$0.86+2.38%$0.89$0.83152,471 shs$23.27 million02/08/2024$0.86$0.84-2.60%$0.86$0.80367,413 shs$22.72 million Related Companies: Exagen Stock Chart Lumos Pharma Stock Chart CytoMed Therapeutics Stock Chart Cumberland Pharmaceuticals Stock Chart Lisata Therapeutics Stock Chart Bullfrog AI Stock Chart Oncternal Therapeutics Stock Chart Lipocine Stock Chart Iterum Therapeutics Stock Chart Benitec Biopharma Stock Chart Receive BIOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIOR) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.